The Growth Opportunities Under Your Nose

Hot-shot growth stocks aren’t the only way to get decent capital returns…

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m generally rubbish at spotting small companies that are on the fast track to heady growth.
 
For proof, look no further than my decision in November 2013 that butchers’ shop chain Crawshaw looked too expensive at 13p. As I write, the shares are at 63p, and the company’s growth prospects apparently look exciting enough to encourage the UK head of supermarket chain Lidl to jump ship and run the business.
 
Which isn’t to say, I hasten to add, that my own portfolio doesn’t have its share of companies exhibiting a decent rate of growth, even though I’m primarily an income investor.

Recovery stocks

Compass Group, for instance, up 95% in four years. GKN, up 146% over roughly the same period. And pasty shop chain Greggs, up 185% in just over two years.

All decent returns I think, and all fairly predictable at the time of purchase — although, as I’ve said before, I have been surprised at the actual extent of Greggs’ stellar rise.
 
Why ‘predictable’? Because the approach I take to looking for growth shares is largely one of looking for shares with recovery potential.
 
Put another way, while I’m rubbish at spotting businesses like Crawshaw’s, I reckon I’m much better at spotting unloved, out-of-favour businesses that have temporarily been hit by headwinds.

Contrarian picks

And as a strategy for finding growth shares, it’s one with some fairly weighty factual evidence on its side.
 
Well-known contrarian investor David Dreman, for instance, has conducted a number of in-depth studies into the long-term performance of various investment strategies.
 
And again and again, a strategy of buying those unloved, out-of-favour businesses — and holding them until they recover — delivers startling outperformance.
 
Put another way, load up on shares with price-earnings (P/E) ratios at below the market average, hold until they reach market average — and then sell, and buy another unloved, out-of-favour business.

Growth + Yield: win both ways

Of course, you don’t have to sell. I don’t. I like to buy unloved, out-of-favour businesses with a decent dividend yield, and simply hold them as income stocks.

And, let’s face it, when a business is hit by adverse headwinds, a low P/E and a high yield often go hand in hand.
 
Nor do you have to look too far to see investors who’ve profited from this ‘buy cheap, hold for the long term’ strategy.
 
Warren Buffett’s fabled purchase of Coca-Cola in the late 1980s, for instance, falls into exactly this category.

347% vs. 42%: take your pick

Or, for a UK example, take Neil Woodford, who is now heading his own investment firm, of course. As I’ve written before, in the 15 years to 31 December 2011, he delivered a 347% return, versus the FTSE All‑Share’s distinctly more modest 42%.
 
And underpinning Mr Woodford’s performance were a series of choice picks of — yes! — those unloved, out-of-favour businesses, bought when others couldn’t get out of them fast enough.
 
Behemoths British American Tobacco and Imperial Tobacco, for instance, bought back in the late 1990s and early 2000s, when the market was convinced that massive tobacco lawsuits lay around the corner.
 
Or GlaxoSmithKline and AstraZeneca, bought when the market was convinced that both businesses had run out of patentable drug discoveries.
 
As Mr Woodford himself told the Daily Telegraph not so long ago:

“The investment industry is full of pseudo‑scientific mumbo‑jumbo, which confuses investors. But what I do is actually quite simple and can be communicated simply: my job is to look for anomalies in the values put on companies by the stock market. Some companies are undervalued by the market, some are overvalued. A fund manager’s job is to find the former, and avoid the latter.

Ignore the naysayers

All of which sounds quite simple and straightforward. Except that it isn’t.
 
Because going against the crowd — which is what contrarian investors do — is never comfortable. Simply put, you’re buying shares that everyone else is selling.
 
Moreover, just because a share is cheap, doesn’t mean that it won’t get cheaper still. So be prepared to stick to your guns and sit it out. Possibly for a lot longer than you’d expected.
 
And yet, the rewards are there.
 
As I said at the beginning: I’m rubbish at picking hot-shot growth stocks. But I like to think that I’m rather better at waiting for a generally well-managed business to recover from some temporary headwinds.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Malcolm owns shares in Compass, GKN, Greggs, GlaxoSmithKline, and AstraZeneca. The Motley Fool has recommended shares in GlaxoSmithKline.

More on Investing Articles

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

Prediction: this will be the FTSE 100’s next great stock!

This FTSE 250 stock has more than doubled in value during the past five years. Our writer thinks it could…

Read more »

Yellow number one sitting on blue background
Investing Articles

Billionaire Bill Ackman has just 1 magnificent AI stock in his FTSE 100-listed fund

Our writer takes a look at the only AI stock held in the portfolio of FTSE 100-listed Pershing Square Holdings.

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

2 penny stocks this Fool thinks could deliver phenomenal returns!

Penny stocks are a risky but exciting asset class to invest in, prone to wild volatility. Our writer thinks he's…

Read more »

Buffett at the BRK AGM
Investing Articles

I’ve just met Warren Buffett’s first rule of investing. Here are 3 ways I did it

Harvey Jones has surprised himself by living up to Warren Buffett's most important investment rule. But is his success down…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

Down 51% in 2024, is this UK growth stock a buy for my Stocks and Shares ISA?

Ben McPoland considers Oxford Nanopore Technologies (LSE:ONT), a UK growth stock that has plunged over 80% since going public in…

Read more »

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

These 3 growth stocks still look dirt cheap despite the FTSE hitting all-time highs

Harvey Jones is hunting for growth stocks that have missed out on the recent FTSE 100 rally and still look…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

Here’s how much I’d need to invest in UK income stocks to retire on £25k a year

Harvey Jones is building his retirement plans on a portfolio of top UK dividend income stocks. There are some great…

Read more »

Investing Articles

If I’d invested £5,000 in BT shares three months ago here’s what I’d have today

Harvey Jones keeps returning to BT shares, wondering whether he finally has the pluck to buy them. The cheaper they…

Read more »